BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22784333)

  • 1. An aggressive B-cell lymphoma with rearrangements of MYC and CCND1 genes: a rare subtype of double-hit lymphoma.
    Durot E; Patey M; Luquet I; Gaillard B; Kolb B; Delmer A
    Leuk Lymphoma; 2013 Mar; 54(3):649-52. PubMed ID: 22784333
    [No Abstract]   [Full Text] [Related]  

  • 2. An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
    Zhou J; Hu L; Zuo M; Zhou Y; Li G; Zhang X
    Am J Clin Pathol; 2020 Jan; 153(1):49-57. PubMed ID: 31433838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
    Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
    Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
    Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
    Scapinello G; Riva M; Branca A; Pizzi M; Bonaldi L; Martines A; Manni S; Visentin A; Trentin L; Semenzato G; Gurrieri C; Piazza F
    Ann Hematol; 2020 Nov; 99(11):2715-2717. PubMed ID: 32671454
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2).
    Koduru PR; Chen W; Garcia R; Fuda F
    Cancer Genet; 2015 Jun; 208(6):303-9. PubMed ID: 25953460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite mantle-cell lymphoma and classical Hodgkin lymphoma.
    Hayes SJ; Banerjee SS; Cook Y; Houghton JB; Menasce LP
    Histopathology; 2006 Apr; 48(5):621-3. PubMed ID: 16623796
    [No Abstract]   [Full Text] [Related]  

  • 9. De novo B lymphoblastic leukemia/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13.
    Subramaniyam S; Fraser CR; Rao PH; Feldman E; Ely S; Mathew S
    Leuk Lymphoma; 2011 Nov; 52(11):2195-9. PubMed ID: 21718139
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathological features of double-hit B-cell lymphomas with MYC and BCL2, BCL6 or CCND1 rearrangements.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Arakawa F; Niino D; Ohshima K
    Pathol Int; 2015 Oct; 65(10):519-27. PubMed ID: 26224092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations].
    Nishijima A; Noguchi Y; Narukawa K; Takano H; Oshikawa G
    Rinsho Ketsueki; 2019; 60(10):1425-1430. PubMed ID: 31695002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
    Zapata M; Budnick SD; Bordoni R; Li S
    Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
    Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
    Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual concomitant rearrangements of Cyclin D1 and MYC genes in blastoid variant of mantle cell lymphoma: Case report and review of literature.
    Delas A; Sophie D; Brousset P; Laurent C
    Pathol Res Pract; 2013 Feb; 209(2):115-9. PubMed ID: 23313364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients.
    Hu Z; Medeiros LJ; Chen Z; Chen W; Li S; Konoplev SN; Lu X; Pham LV; Young KH; Wang W; Hu S
    Am J Surg Pathol; 2017 Feb; 41(2):216-224. PubMed ID: 27776009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
    Motlló C; Grau J; Juncà J; Ruiz N; Mate JL; Orna E; Navarro JT; Vives S; Sancho JM; Esteban D; Granada I; Feliu E; Ribera JM; Millá F
    Cancer Genet Cytogenet; 2010 Dec; 203(2):328-32. PubMed ID: 21156254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.
    Seok Y; Kim J; Choi JR; Kim YR; Park SJ; Kim SJ; Song J; Lee KA
    Ann Lab Med; 2012 Jan; 32(1):95-8. PubMed ID: 22259787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
    Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
    Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
    Iaccarino I; Afify L; Aukema SM; Reddemann K; Schütt P; Flür M; Klapper W
    Haematologica; 2018 Sep; 103(9):e432-e435. PubMed ID: 29773591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.